Follow
Bertrand Nyuykonge
Bertrand Nyuykonge
ErasmusMC University Medical Center Rotterdam, The Netherlands
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma
W Lim, B Nyuykonge, K Eadie, M Konings, J Smeets, A Fahal, A Bonifaz, ...
PLoS Neglected Tropical Diseases 16 (2), e0010159, 2022
252022
Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico
B Nyuykonge, CHW Klaassen, WHA Zandijk, GS de Hoog, SA Ahmed, ...
Journal of the European Academy of Dermatology and Venereology 34 (8), 1828-1834, 2020
172020
The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach
W Lim, E Siddig, K Eadie, B Nyuykonge, S Ahmed, A Fahal, A Verbon, ...
PLOS Neglected Tropical Diseases 14 (12), e0008897, 2020
142020
Mycetoma caused by Microascus gracilis: a novel agent of human eumycetoma in Sudan
NA Mhmoud, EE Siddig, B Nyuykonge, SM Bakhiet, WWJ van de Sande, ...
Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (4 …, 2021
132021
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole
B Nyuykonge, W Lim, L van Amelsvoort, A Bonifaz, A Fahal, H Badali, ...
Mycoses 65 (6), 650-655, 2022
122022
Human actinomycetoma caused by Actinomadura mexicana in Sudan: the first report
EE Siddig, B Nyuykonge, MT Ahmed, R Hassan, ESA Saad, NA Mhmoud, ...
Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (4 …, 2021
92021
A Short-Tandem-Repeat Assay (MmySTR) for Studying Genetic Variation in Madurella mycetomatis
B Nyuykonge, K Eadie, WHA Zandijk, SA Ahmed, M Desnos-Ollivier, ...
Journal of Clinical Microbiology 59 (3), 10.1128/jcm. 02331-20, 2021
82021
Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma
B Nyuykonge, EE Siddig, NA Mhmoud, BA Nyaoke, EE Zijlstra, A Verbon, ...
Mycoses 65 (12), 1170-1178, 2022
72022
Comparing the performance of the common used eumycetoma diagnostic tests
EE Siddig, B Nyuykonge, NA Mhmoud, OB Abdallah, MEN Bahar, ...
Mycoses 66 (5), 420-429, 2023
62023
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for In Vitro Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole …
B Nyuykonge, L van Amelsvoort, K Eadie, AH Fahal, A Verbon, ...
Antimicrobial Agents and Chemotherapy 65 (9), 10.1128/aac. 00433-21, 2021
62021
Madurella mycetomatis grains within a eumycetoma lesion are clonal
B Nyuykonge, EE Siddig, M Konings, S Bakhiet, A Verbon, ...
Medical Mycology 60 (7), myac051, 2022
42022
Pyomelanin secretion in Madurella mycetomatis interferes with spectrophotometric endpoint reading using the Sensititre YeastOne alamarBlue assay but not with visual endpoint …
B Nyuykonge, PD Croughs, AH Fahal, A Verbon, WWJ van de Sande
Antimicrobial Agents and Chemotherapy 64 (1), 10.1128/aac. 01532-19, 2019
42019
Staphylococcus aureus causing primary foot botryomycosis mimicking actinomycetoma: a case report from Sudan
EE Siddig, B Nyuykonge, OELH Bakheit, OB Hassan, ES Ahmed, ...
International Journal of Infectious Diseases 124, 224-226, 2022
32022
Wako β‐D‐glucan assay can be used to measure serum β‐D‐glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis
B Nyuykonge, E Siddig, NA Mhmoud, S Bakhiet, E Zijlstra, A Verbon, ...
Journal of the European Academy of Dermatology and Venereology 37 (4), 783-786, 2023
22023
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo
M Konings, K Eadie, N Strepis, B Nyuykonge, AH Fahal, A Verbon, ...
Medical Mycology 61 (11), myad118, 2023
12023
Using (1,3)‐β‐D‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis
B Nyuykonge, EE Siddig, BA Nyaoke, EE Zijlstra, A Verbon, SM Bakhiet, ...
Mycoses 67 (1), e13664, 2024
2024
Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard
E Siddig, B Nyuykonge, N Mhmoud, O Abdallah, M Bahar, E Ahmed, ...
Medical Mycology 60 (S1), 263, 2022
2022
S4. 5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard
E Siddig, B Nyuykonge, N Mhmoud, O Abdallah, M Bahar, E Ahmed, ...
Medical Mycology 60 (Supplement_1), myac072S45d, 2022
2022
S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole …
B Nyuykonge, E Siddig, N Mhmoud, B Nyaoke, E Zijlstra, A Verbon, ...
Medical Mycology 60 (Supplement_1), myac072S45c, 2022
2022
Correction for Nyuykonge et al., “Pyomelanin Secretion in Madurella mycetomatis Interferes with Spectrophotometric Endpoint Reading Using the Sensititre …
B Nyuykonge, PD Croughs, AH Fahal, A Verbon, WWJ van de Sande
Antimicrobial Agents and Chemotherapy 64 (11), 10.1128/aac. 01848-20, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20